Table of Contents
02
04
08 12
14
16 20 24
26
28 30 32
Section 1 : Transforming the Drug Development Landscape
Alpha-synuclein : Major Deal Pushes Vaccine Further in Testing
LRRK2 : Enabling Progress through the Pipeline Also Heading to the Clinic
Section 2 : Understanding the Biology of Parkinson ’ s
PPMI : A United Effort to Predict and Prevent Parkinson ’ s
Environmental Exposures : Uncovering their Role in Parkinson ’ s
Also Heard around the Lab
Section 3 : Creating Momentum with Our Community
Inclusiveness in Research : A Parkinson ’ s Cure for All Parkinson ’ s Buddy Network : Cultivating Connections Also Seen in the Headlines